{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:11:45Z","timestamp":1780927905940,"version":"3.54.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82503956"],"award-info":[{"award-number":["82503956"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81602732"],"award-info":[{"award-number":["81602732"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Postdoctoral Fellowship Program of China Postdoctoral Science Foundation","award":["GZC20251466"],"award-info":[{"award-number":["GZC20251466"]}]},{"DOI":"10.13039\/501100002858","name":"the China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2025M782198"],"award-info":[{"award-number":["2025M782198"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Sichuan Province","award":["2026NSFSC1919"],"award-info":[{"award-number":["2026NSFSC1919"]}]},{"name":"the Postdoctor Research Fund of West China Hospital, Sichuan University","award":["2025HXBH123"],"award-info":[{"award-number":["2025HXBH123"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"DOI":"10.1007\/s11764-026-02054-w","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:23:07Z","timestamp":1780917787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychosocial predictors of chemotherapy-induced nausea and vomiting among chemotherapy-na\u00efve cancer patients: a prospective multicenter cohort study"],"prefix":"10.1007","author":[{"given":"Bin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongna","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuning","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaotiao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"4","key":"2054_CR1","first-page":"219","volume":"13","author":"CC Sun","year":"2005","unstructured":"Sun CC, Bodurka DC, Weaver CB, Rasu R, Wolf JK, Bevers MW, et al. Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer. 2005;13(4):219\u201327.","journal-title":"Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer"},{"issue":"9","key":"2054_CR2","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1200\/JCO-24-01308","volume":"43","author":"H Zhou","year":"2025","unstructured":"Zhou H, Zhao Y, Zhang M, Yao J, Leng S, Li X, et al. Randomized, phase III trial of mixed formulation of fosrolapitant and palonosetron (HR20013) in preventing cisplatin-based highly emetogenic chemotherapy-induced nausea and vomiting: PROFIT. J Clin Oncol. 2025;43(9):1123\u201336.","journal-title":"J Clin Oncol"},{"issue":"6","key":"2054_CR3","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/annonc\/mdv138","volume":"26","author":"K Jordan","year":"2015","unstructured":"Jordan K, Jahn F, Aapro M. Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review. Ann Oncol. 2015;26(6):1081\u201390.","journal-title":"Ann Oncol"},{"key":"2054_CR4","doi-asserted-by":"publisher","unstructured":"Belluomini L, Avancini A, Sposito M, Pontolillo L, Tregnago D, Trestini I, et al. Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: the road to success. Crit Rev Oncol Hematol. 2024;201:104444, 104444. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104444.","DOI":"10.1016\/j.critrevonc.2024.104444"},{"key":"2054_CR5","doi-asserted-by":"publisher","unstructured":"Kennedy SKF, Goodall S, Lee SF, DeAngelis C, Jocko A, Charbonneau F, et al. 2020 ASCO, 2023 NCCN, 2023 MASCC\/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients. Support Care Cancer. 2020;32(5):280, 280. https:\/\/doi.org\/10.1007\/s00520-024-08462-x.","DOI":"10.1007\/s00520-024-08462-x"},{"key":"2054_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115451","volume":"222","author":"K Jordan","year":"2025","unstructured":"Jordan K, de Azambuja E, Garc\u00eda Del Barrio M, Jahn F, Di Palma M, Scott\u00e9 F, et al. Going beyond the 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting. Eur J Cancer. 2025;222:115451.","journal-title":"Eur J Cancer"},{"issue":"2","key":"2054_CR7","doi-asserted-by":"publisher","first-page":"102195","DOI":"10.1016\/j.esmoop.2023.102195","volume":"9","author":"J Herrstedt","year":"2023","unstructured":"Herrstedt J, Clark-Snow R, Ruhlmann CH, Molassiotis A, Olver I, Rapoport BL, et al. 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting. ESMO Open. 2023;9(2):102195. https:\/\/doi.org\/10.1016\/j.esmoop.2023.102195.","journal-title":"ESMO Open"},{"issue":"11","key":"2054_CR8","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.annonc.2020.07.020","volume":"31","author":"P Grimison","year":"2020","unstructured":"Grimison P, Mersiades A, Kirby A, Lintzeris N, Morton R, Haber P, et al. Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial. Ann Oncol. 2020;31(11):1553\u201360.","journal-title":"Ann Oncol"},{"issue":"1","key":"2054_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1200\/JOP.2012.000816","volume":"10","author":"JW Gilmore","year":"2014","unstructured":"Gilmore JW, Peacock NW, Gu A, Szabo S, Rammage M, Sharpe J, et al. Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community oncology practice: INSPIRE study. J Oncol Pract. 2014;10(1):68\u201374.","journal-title":"J Oncol Pract"},{"key":"2054_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.10.017","author":"A Molassiotis","year":"2025","unstructured":"Molassiotis A, Jordan K, Karthaus M, Dranitsaris G, Roeland EJ, Schwartzberg L, et al. Personalised antiemetic prophylaxis with NEPA for patients at high risk of chemotherapy-induced nausea and vomiting receiving moderately emetogenic chemotherapy: results from the randomised, multinational MyRisk trial. Ann Oncol. 2025. https:\/\/doi.org\/10.1016\/j.annonc.2025.10.017.","journal-title":"Ann Oncol"},{"issue":"2","key":"2054_CR11","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/annonc\/mdx698","volume":"29","author":"L Zhang","year":"2018","unstructured":"Zhang L, Lu S, Feng J, Dechaphunkul A, Chang J, Wang D, et al. A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC). Ann Oncol. 2018;29(2):452\u20138.","journal-title":"Ann Oncol"},{"key":"2054_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2147\/CMAR.S447546","volume":"16","author":"W Yeo","year":"2024","unstructured":"Yeo W, Ngai NTY, Yip CCH, Mo FKF, Yeo VA, Ko JWH, et al. Risk factors associated with chemotherapy-induced nausea and vomiting among women with breast cancer receiving highly emetogenic chemotherapy: individual patient-based analysis of three prospective antiemetic trials. Cancer Manag Res. 2024;16:283\u201397.","journal-title":"Cancer Manag Res"},{"issue":"6","key":"2054_CR13","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/annonc\/mdx120","volume":"28","author":"F Scott\u00e9","year":"2017","unstructured":"Scott\u00e9 F. Identifying predictive factors of chemotherapy-induced nausea and vomiting (CINV): a novel approach. Ann Oncol. 2017;28(6):1165\u20137.","journal-title":"Ann Oncol"},{"issue":"3","key":"2054_CR14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1345\/aph.1L437","volume":"43","author":"V Shih","year":"2009","unstructured":"Shih V, Wan HS, Chan A. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide. Ann Pharmacother. 2009;43(3):444\u201352.","journal-title":"Ann Pharmacother"},{"issue":"6","key":"2054_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000431256","volume":"84","author":"L Grassi","year":"2015","unstructured":"Grassi L, Berardi MA, Ruffilli F, Meggiolaro E, Andritsch E, Sirgo A, et al. Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study. Psychother Psychosom. 2015;84(6):339\u201347.","journal-title":"Psychother Psychosom"},{"issue":"6","key":"2054_CR16","doi-asserted-by":"publisher","first-page":"E52","DOI":"10.1097\/NCC.0000000000000342","volume":"39","author":"VE Di Mattei","year":"2016","unstructured":"Di Mattei VE, Carnelli L, Carrara L, Bernardi M, Crespi G, Rancoita PMV, et al. Chemotherapy-induced nausea and vomiting in women with gynecological cancer: a preliminary single-center study investigating medical and psychosocial risk factors. Cancer Nurs. 2016;39(6):E52\u20139.","journal-title":"Cancer Nurs"},{"issue":"2","key":"2054_CR17","first-page":"139","volume":"10","author":"A Molassiotis","year":"2002","unstructured":"Molassiotis A, Yam BM, Yung H, Chan FY, Mok TS. Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients. Support Care Cancer. 2002;10(2):139\u201345.","journal-title":"Support Care Cancer"},{"issue":"2","key":"2054_CR18","first-page":"103","volume":"2","author":"RM Navari","year":"2017","unstructured":"Navari RM. Cancer patients at high risk for chemotherapy-induced nausea and vomiting \u2013 prediction assessments\/tools. Expert Rev Qual Life Cancer Care. 2017;2(2):103\u20138.","journal-title":"Expert Rev Qual Life Cancer Care"},{"issue":"6","key":"2054_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.jpainsymman.2015.12.317","volume":"51","author":"A Molassiotis","year":"2016","unstructured":"Molassiotis A, Lee PH, Burke TA, Dicato M, Gascon P, Roila F, et al. Anticipatory nausea, risk factors, and its impact on chemotherapy-induced nausea and vomiting: results from the Pan European Emesis Registry Study. J Pain Symptom Manage. 2016;51(6):987\u201393.","journal-title":"J Pain Symptom Manage"},{"issue":"12","key":"2054_CR20","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1200\/JCO.2005.09.050","volume":"23","author":"DG Warr","year":"2005","unstructured":"Warr DG, Hesketh PJ, Gralla RJ, Muss HB, Herrstedt J, Eisenberg PD, et al. Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy. J Clin Oncol. 2005;23(12):2822\u201330.","journal-title":"J Clin Oncol"},{"issue":"2","key":"2054_CR21","first-page":"171","volume":"15","author":"SC Higgins","year":"2007","unstructured":"Higgins SC, Montgomery GH, Bovbjerg DH. Distress before chemotherapy predicts delayed but not acute nausea. Support Care Cancer. 2007;15(2):171\u20137.","journal-title":"Support Care Cancer"},{"key":"2054_CR22","unstructured":"Lazarus RS, Folkman S. Stress, appraisal, and coping. Springer Publishing Company; 1984."},{"key":"2054_CR23","first-page":"1","volume-title":"The international encyclopedia of health communication","author":"BM Wolf","year":"2022","unstructured":"Wolf BM, Fisher CL. Stress, appraisal, and coping theory. In: The international encyclopedia of health communication. 2022. p. 1\u20136."},{"issue":"1","key":"2054_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.6004\/jnccn.2022.0004","volume":"20","author":"KA Donovan","year":"2022","unstructured":"Donovan KA, Handzo G, Corbett C, Vanderlan J, Brewer BW, Ahmed K. NCCN distress thermometer problem list update. J Natl Compr Canc Netw. 2022;20(1):96\u20138.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"2054_CR25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1186\/s40359-024-02081-1","volume":"12","author":"C Zhu","year":"2024","unstructured":"Zhu C, Chen Q, Du W, Xu H, He X. Evaluating psychological distress in Chinese patients with head and neck squamous cell carcinoma planned for radiotherapy: a cross-sectional study using the distress thermometer. BMC Psychol. 2024;12(1):577. https:\/\/doi.org\/10.1186\/s40359-024-02081-1.","journal-title":"BMC Psychol"},{"issue":"3","key":"2054_CR26","first-page":"439","volume":"6","author":"S Greer","year":"1987","unstructured":"Greer S, Watson M. Mental adjustment to cancer: its measurement and prognostic importance. Cancer Surv. 1987;6(3):439\u201353.","journal-title":"Cancer Surv"},{"issue":"6","key":"2054_CR27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/pon.672","volume":"12","author":"SM Ho","year":"2003","unstructured":"Ho SM, Fung WK, Chan CL, Watson M, Tsui YK. Psychometric properties of the Chinese version of the Mini-Mental Adjustment to Cancer (MINI-MAC) scale. Psychooncology. 2003;12(6):547\u201356.","journal-title":"Psychooncology"},{"key":"2054_CR28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fphar.2020.00329","volume":"11","author":"ASM Mosa","year":"2020","unstructured":"Mosa ASM, Hossain AM, Lavoie BJ, Yoo I. Patient-related risk factors for chemotherapy-induced nausea and vomiting: a systematic review. Front Pharmacol. 2020;11:329. https:\/\/doi.org\/10.3389\/fphar.2020.00329.","journal-title":"Front Pharmacol"},{"key":"2054_CR29","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejphar.2013.10.015","volume":"722","author":"D Warr","year":"2014","unstructured":"Warr D. Prognostic factors for chemotherapy induced nausea and vomiting. Eur J Pharmacol. 2014;722:192\u20136.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"2054_CR30","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jpainsymman.2013.06.012","volume":"47","author":"A Molassiotis","year":"2014","unstructured":"Molassiotis A, Aapro M, Dicato M, Gascon P, Novoa SA, Isambert N, et al. Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study. J Pain Symptom Manage. 2014;47(5):839-48.e4.","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"2054_CR31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00520-023-08222-3","volume":"32","author":"F Scott\u00e9","year":"2023","unstructured":"Scott\u00e9 F, Schwartzberg L, Iihara H, Aapro M, Gralla R, Hesketh PJ, et al. 2023 updated MASCC\/ESMO Consensus recommendations: prevention of nausea and vomiting following moderately emetic risk antineoplastic agents. Support Care Cancer. 2023;32(1):45.  https:\/\/doi.org\/10.1007\/s00520-023-08222-3.","journal-title":"Support Care Cancer"},{"issue":"9","key":"2054_CR32","first-page":"3729","volume":"24","author":"JY Tan","year":"2016","unstructured":"Tan JY, Suen LK, Molassiotis A. Psychometric assessment of the Chinese version of the MASCC Antiemesis Tool (MAT) for measuring chemotherapy-induced nausea and vomiting. Support Care Cancer. 2016;24(9):3729\u201337.","journal-title":"Support Care Cancer"},{"issue":"9","key":"2054_CR33","first-page":"2701","volume":"147","author":"Y Sun","year":"2021","unstructured":"Sun Y, Zheng Y, Yang X, Xie K, Du C, He L, et al. Incidence of chemotherapy-induced nausea and vomiting among cancer patients receiving moderately to highly emetogenic chemotherapy in cancer centers in Sichuan. China J Cancer Res Clin Oncol. 2021;147(9):2701\u20138.","journal-title":"China J Cancer Res Clin Oncol"},{"issue":"8","key":"2054_CR34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00520-023-07978-y","volume":"31","author":"R Chow","year":"2023","unstructured":"Chow R, Yin LB, Baqri W, Huang R, Boldt G, Younus J, et al. Prevalence and predictors of long-delayed (>\u2009120\u00a0h) chemotherapy-induced nausea and vomiting (CINV)\u2014a systematic review and individual patient data meta-analysis. Support Care Cancer. 2023;31(8):505. https:\/\/doi.org\/10.1007\/s00520-023-07978-y","journal-title":"Support Care Cancer"},{"key":"2054_CR35","doi-asserted-by":"publisher","unstructured":"Dufner V, Kessler AF, Just L, Hau P, Bumes E, Pels HJ, et al. The Emesis trial: depressive glioma patients are more affected by chemotherapy-induced nausea and vomiting. Front Neurol. 2022;13:773265, 773265. https:\/\/doi.org\/10.3389\/fneur.2022.773265.","DOI":"10.3389\/fneur.2022.773265"},{"issue":"1","key":"2054_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103836","volume":"9","author":"S Peng","year":"2022","unstructured":"Peng S, Xiao F, Chen M, Gao H. Tumor-microenvironment-responsive nanomedicine for enhanced cancer immunotherapy. Adv Sci (Weinh). 2022;9(1):e2103836.","journal-title":"Adv Sci (Weinh)"},{"issue":"2","key":"2054_CR37","first-page":"557","volume":"26","author":"R Clark-Snow","year":"2018","unstructured":"Clark-Snow R, Affronti ML, Rittenberg CN. Chemotherapy-induced nausea and vomiting (CINV) and adherence to antiemetic guidelines: results of a survey of oncology nurses. Support Care Cancer. 2018;26(2):557\u201364.","journal-title":"Support Care Cancer"},{"issue":"8","key":"2054_CR38","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/annonc\/mds021","volume":"23","author":"M Aapro","year":"2012","unstructured":"Aapro M, Molassiotis A, Dicato M, Pel\u00e1ez I, Rodr\u00edguez-Lescure \u00c1, Pastorelli D, et al. The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER). Ann Oncol. 2012;23(8):1986\u201392.","journal-title":"Ann Oncol"},{"issue":"8","key":"2054_CR39","first-page":"4269","volume":"29","author":"R Chow","year":"2021","unstructured":"Chow R, Chiu L, Herrstedt J, Aapro M, Lock M, DeAngelis C, et al. Cost-effectiveness analysis of olanzapine-containing antiemetic therapy for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) in highly emetogenic chemotherapy (HEC) patients. Support Care Cancer. 2021;29(8):4269\u201375.","journal-title":"Support Care Cancer"},{"issue":"12","key":"2054_CR40","first-page":"4525","volume":"27","author":"N Mahendraratnam","year":"2019","unstructured":"Mahendraratnam N, Farley JF, Basch E, Proctor A, Wheeler SB, Dusetzina SB. Characterizing and assessing antiemetic underuse in patients initiating highly emetogenic chemotherapy. Support Care Cancer. 2019;27(12):4525\u201334.","journal-title":"Support Care Cancer"},{"issue":"18 Suppl","key":"2054_CR41","first-page":"S398","volume":"24","author":"SA Soefje","year":"2018","unstructured":"Soefje SA. Strategies to improve CINV outcomes in managed care. Am J Manag Care. 2018;24(18 Suppl):S398-s404.","journal-title":"Am J Manag Care"},{"issue":"2","key":"2054_CR42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1200\/JCO.21.01315","volume":"40","author":"A Hata","year":"2022","unstructured":"Hata A, Okamoto I, Inui N, Okada M, Morise M, Akiyoshi K, et al. Randomized, double-blind, phase III study of fosnetupitant versus fosaprepitant for prevention of highly emetogenic chemotherapy-induced nausea and vomiting: CONSOLE. J Clin Oncol. 2022;40(2):180\u20138.","journal-title":"J Clin Oncol"},{"key":"2054_CR43","doi-asserted-by":"publisher","unstructured":"Varangot-Reille C, Sanger GJ, Andrews PLR, Herranz-Gomez A, Suso-Mart\u00ed L, de la Nava J, et al. Neural networks involved in nausea in adult humans: a systematic review. Auton Neurosci. 2023;245:103059, 103059. https:\/\/doi.org\/10.1016\/j.autneu.2022.103059.","DOI":"10.1016\/j.autneu.2022.103059"},{"key":"2054_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115797","author":"W Zhong","year":"2021","unstructured":"Zhong W, Shahbaz O, Teskey G, Beever A, Kachour N, Venketaraman V, et al. Mechanisms of nausea and vomiting: current knowledge and recent advances in intracellular emetic signaling systems. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22115797.","journal-title":"Int J Mol Sci"},{"key":"2054_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2012.01.046","volume":"684","author":"C Rojas","year":"2012","unstructured":"Rojas C, Slusher BS. Pharmacological mechanisms of 5-HT3 and tachykinin NK1 receptor antagonism to prevent chemotherapy-induced nausea and vomiting. Eur J Pharmacol. 2012;684:1\u20137.","journal-title":"Eur J Pharmacol"},{"issue":"28","key":"2054_CR46","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1200\/JCO.2017.74.4789","volume":"35","author":"PJ Hesketh","year":"2017","unstructured":"Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, et al. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017;35(28):3240\u201361.","journal-title":"J Clin Oncol"},{"issue":"5","key":"2054_CR47","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s10147-015-0786-7","volume":"20","author":"K Tamura","year":"2015","unstructured":"Tamura K, Aiba K, Saeki T, Nakanishi Y, Kamura T, Baba H, et al. Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan. Int J Clin Oncol. 2015;20(5):855\u201365.","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"2054_CR48","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1037\/a0028223","volume":"32","author":"TE Arpawong","year":"2013","unstructured":"Arpawong TE, Richeimer SH, Weinstein F, Elghamrawy A, Milam JE. Posttraumatic growth, quality of life, and treatment symptoms among cancer chemotherapy outpatients. Health Psychol. 2013;32(4):397\u2013408.","journal-title":"Health Psychol"},{"issue":"4","key":"2054_CR49","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/cercor\/bhs073","volume":"23","author":"V Napadow","year":"2013","unstructured":"Napadow V, Sheehan JD, Kim J, Lacount LT, Park K, Kaptchuk TJ, et al. The brain circuitry underlying the temporal evolution of nausea in humans. Cereb Cortex. 2013;23(4):806\u201313.","journal-title":"Cereb Cortex"},{"issue":"18","key":"2054_CR50","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s40265-016-0664-2","volume":"76","author":"ED Deeks","year":"2016","unstructured":"Deeks ED. Granisetron extended-release injection: a review in chemotherapy-induced nausea and vomiting. Drugs. 2016;76(18):1779\u201386.","journal-title":"Drugs"},{"issue":"3","key":"2054_CR51","first-page":"76","volume":"10","author":"DJ Zook","year":"1983","unstructured":"Zook DJ, Yasko JM. Psychologic factors: their effect on nausea and vomiting experienced by clients receiving chemotherapy. Oncol Nurs Forum. 1983;10(3):76\u201381.","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"2054_CR52","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1200\/JCO.1997.15.1.116","volume":"15","author":"D Osoba","year":"1997","unstructured":"Osoba D, Zee B, Pater J, Warr D, Latreille J, Kaizer L. Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of life and symptom control committees of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 1997;15(1):116\u201323.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2054_CR53","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00520-023-08225-0","volume":"32","author":"A Molassiotis","year":"2023","unstructured":"Molassiotis A, Affronti ML, Fleury M, Olver I, Giusti R, Scotte F. 2023 MASCC\/ESMO consensus antiemetic guidelines related to integrative and non-pharmacological therapies. Support Care Cancer. 2023;32(1):30. https:\/\/doi.org\/10.1007\/s00520-023-08225-0.","journal-title":"Support Care Cancer"},{"issue":"7","key":"2054_CR54","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s10147-024-02536-w","volume":"29","author":"M Kobayashi","year":"2023","unstructured":"Kobayashi M, Kako J, Iba A, Okuyama A, Ozawa K, Abe M, et al. Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023. Int J Clin Oncol. 2023;29(7):889\u201398.","journal-title":"Int J Clin Oncol"},{"key":"2054_CR55","unstructured":"National Comprehensive Cancer Network (2024) NCCN Guidelines Version 1: Antiemesis, https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/antiemesis.pdf. Accessed 7 June 2024."},{"issue":"5","key":"2054_CR56","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/cam4.2863","volume":"9","author":"JJ Hunter","year":"2020","unstructured":"Hunter JJ, Maunder RG, Sui D, Esplen MJ, Chaoul A, Fisch MJ, et al. A randomized trial of nurse-administered behavioral interventions to manage anticipatory nausea and vomiting in chemotherapy. Cancer Med. 2020;9(5):1733\u201340.","journal-title":"Cancer Med"},{"issue":"6","key":"2054_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.102047","volume":"8","author":"L Grassi","year":"2023","unstructured":"Grassi L, Zachariae R, Caruso R, Palagini L, Campos-R\u00f3denas R, Riba MB, et al. Insomnia in adult patients with cancer: ESMO Clinical Practice Guideline. ESMO Open. 2023;8(6):102047.","journal-title":"ESMO Open"},{"issue":"1","key":"2054_CR58","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1186\/s12888-024-06379-7","volume":"24","author":"C Cui","year":"2024","unstructured":"Cui C, Wang L. Mediating effect of social constraints in the association between stigma and depressive symptoms in Chinese breast cancer patients. BMC Psychiatry. 2024;24(1):923.","journal-title":"BMC Psychiatry"},{"key":"2054_CR59","doi-asserted-by":"publisher","first-page":"1365246","DOI":"10.3389\/fpsyg.2024.1365246","volume":"15","author":"M Liu","year":"2024","unstructured":"Liu M, Qin F, Wang D. A study of the mediating effect of social support on self-disclosure and demoralization in Chinese older adult homebound breast cancer patients. Front Psychol. 2024;15:1365246. https:\/\/doi.org\/10.3389\/fpsyg.2024.1365246.","journal-title":"Front Psychol"},{"issue":"1","key":"2054_CR60","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s40359-024-01927-y","volume":"12","author":"Y Ding","year":"2024","unstructured":"Ding Y, Wang X, Zhang F, Yan H, Liu Y, Zhang L. The relationship between perceived social support, coping style, and the quality of life and psychological state of lung cancer patients. BMC Psychol. 2024;12(1):439.","journal-title":"BMC Psychol"},{"issue":"1","key":"2054_CR61","first-page":"131","volume":"19","author":"TA Burke","year":"2011","unstructured":"Burke TA, Wisniewski T, Ernst FR. Resource utilization and costs associated with chemotherapy-induced nausea and vomiting (CINV) following highly or moderately emetogenic chemotherapy administered in the US outpatient hospital setting. Support Care Cancer. 2011;19(1):131\u201340.","journal-title":"Support Care Cancer"},{"issue":"4","key":"2054_CR62","doi-asserted-by":"publisher","first-page":"E133","DOI":"10.1188\/12.CJON.E133-E141","volume":"16","author":"PH Viale","year":"2012","unstructured":"Viale PH, Grande C, Moore S. Efficacy and cost: avoiding undertreatment of chemotherapy-induced nausea and vomiting. Clin J Oncol Nurs. 2012;16(4):E133-41.","journal-title":"Clin J Oncol Nurs"},{"issue":"1","key":"2054_CR63","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2217\/fon-2022-0972","volume":"19","author":"WW Nelson","year":"2023","unstructured":"Nelson WW, Vaidya V, Scott JA, Wang B, Lambert H, Holmes B, et al. Antiemetic use and chemotherapy induced nausea and vomiting related hospitalization costs after highly or moderately emetogenic chemotherapy. Future Oncol. 2023;19(1):29\u201336.","journal-title":"Future Oncol"},{"key":"2054_CR64","doi-asserted-by":"publisher","first-page":"913129","DOI":"10.3389\/fpubh.2022.913129","volume":"10","author":"X Xu","year":"2022","unstructured":"Xu X, Bao Y, Xu K, Zhang Z, Zhao N, Li X. Economic value of fosaprepitant-containing regimen in the prevention of chemotherapy-induced nausea and vomiting in China: cost-effectiveness and budget impact analysis. Front Public Health. 2022;10:913129.  https:\/\/doi.org\/10.3389\/fpubh.2022.913129.","journal-title":"Front Public Health"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-026-02054-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-026-02054-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-026-02054-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:02:27Z","timestamp":1780923747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-026-02054-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":64,"alternative-id":["2054"],"URL":"https:\/\/doi.org\/10.1007\/s11764-026-02054-w","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee on Biomedical Research of West China Hospital, and the other collaborating centers obtained approval from their respective institutional ethics committees.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}